Azathioprine for atopic dermatitis

Clinical and Experimental Dermatology

Volumn 26, Issue 5, 2001, Pages 369-375

  Meggitt, S J ^a,b   Reynolds, N J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; THIOPURINE METHYLTRANSFERASE;

ATOPIC DERMATITIS; BONE MARROW TOXICITY; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG USE; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

6-MERCAPTOPURINE; AZATHIOPRINE; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHYLTRANSFERASES; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034833065     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2001.00837.x     Document Type: Review

References (39)

1. Azathioprine lymphocytotoxicity. Potentially lethal damage by its imidazole derivatives
2. Azathioprine in dermatology: A survey of current practice in the U.K.
3. Effect of narrow-band ultraviolet B (TL01) and ultraviolet A phototherapy in adult atopic eczema: A randomised controlled trial
4. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis
5. Carcinogenicity of UVB phototherapy assessed
6. Renal function after 10 years' treatment with cyclosporin for psoriasis
7. Cyclosporin in atopic dermatitis: Time to relapse and effect of intermittent therapy
8. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis
9. A short-term trial of tacrolimus ointment for atopic dermatitis
10. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children
11. Safety and efficacy of 1 year tacrolimus ointment monotherapy in adults with atopic dermatitis
12. Long-term efficacy of medium dose UVA1 phototherapy in atopic dermatitis
13. Oral psoralen photochemotherapy in severe childhood atopic eczema: An update
14. An approach to the treatment of moderate to severe psoriasis with rotational therapy
15. Traitement immuno-suppressif chez 15 patients atteints d'affections auto-immunes ou de maladies ayants une pathogenie immunologique
16. Treatment of eczema with cyclophosphamide and azathioprine
17. Azathioprine in dermatology
18. Retrospective review of the use of azathioprine in severe atopic dermatitis
19. The use of azathioprine in severe adult atopic eczema
20. Azathioprine in dermatological practice: An overview with special emphasis on its use in non-bullous inflammatory dermatoses
21. Azathioprine in severe childhood eczema: Value of TPMT as a predictor of outcome and safety in treatment
22. Immunoglobulin E in 'healed' atopic dermatitis and after treatment with corticosteroids and azathoprine
23. Azathioprine in the treatment of eczema and actinic reticuloid
24. Azathioprine in dermatology: A review in the light of advances in understanding methylation pharmacogenetics
25. Skin cancer after renal transplantation: The causal role of azathioprine
26. Long term neoplasia risk after azathioprine treatment in inflammatory bowel disease
27. The incidence of immunosuppression-related skin disease in long-term transplant patients
28. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy and lactation
29. Pancytopenia related to azathioprine: An enzyme deficiency caused by a common genetic polymorphism: A review
30. Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity
31. Genetic polymorphism of thiopurine S-methyltransferase: Molecular mechanisms and clinical importance
32. Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism
33. Thiopurine pharmacogenetics in leukaemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations
34. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
35. Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient
36. Pharmacokinetics of azathioprine after repeated oral and single intravenous administration
37. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus
38. The role of genetic variation in thiopurinemethyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients
39. Six area, six sign atopic dermatitis (SASSAD) severity score: A simple system for monitoring disease activity in atopic dermatitis